Epidemiologic Study of Hepatocellular Carcinoma in the US
Completed
Conditions studied: Hepatocellular Carcinoma
In brief
The purpose of this study is: * to investigate the risk factors of HCC among Americans with focus on lifestyle factors and energy balance. * to identify single nucleotide polymorphisms (SNPs) and haplotypes that are associated with HCC risk through a genome-wide search. * to assess if genetic susceptibility differs by hepatitis virus infection or lifestyle factors, and to explore if there are interplays or effect modifications between genetic factors and viral infection or lifestyle factors.
Key facts
- Study ID
- NCT02358070
- Run by
- Stanford University
- People needed
- 45
- Starts
- 2015-04-01
- Expected to finish
- 2016-09-01
- Last updated by the study team
- 2020-03-24
Who can join
Age: 35 and older, up to 84. Sex: any. Healthy volunteers: accepted.
Where it is running
- Stanford Liver Transplant Clinic — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.